title: Clinical practice. Latent tuberculosis infection in the United States.
authors.affiliation: Boston University School of Public Health, Boston, USA.
authors.forename: C Robert
authors.initials: CR
authors.lastname: Horsburgh
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Rubin
mesh_terms: D000328:Adult; D000942:Antigens, Bacterial; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D014943:Global Health; D006801:Humans; D007371:Interferon-gamma / Q000032:analysis* / Q000378:metabolism; D007538:Isoniazid / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000502:physiology; D017410:Practice Guidelines as Topic; D012293:Rifampin / Q000627:therapeutic use; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy*; D017735:Virus Latency
chemical_list: D000942:Antigens, Bacterial; D000995:Antitubercular Agents; D007371:Interferon-gamma; D007538:Isoniazid; D012293:Rifampin